Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Renal Insufficiency, Chronic 1Lymphoma, Follicular 1Diabetes Mellitus 1

Interventions

pembrolizumab 1024Carboplatin 966Paclitaxel 933Gemcitabine 794Cisplatin 753Docetaxel 684Bevacizumab 609Pemetrexed 504Nivolumab 487Cyclophosphamide 474Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 373Oxaliplatin 348Injections 347atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 246Doxorubicin 241Ipilimumab 226fludarabine 220Lenalidomide 220Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × DM199 × Clear all
NCT03795389 2021-09-13

Study to Assess PK, Safety and Tolerability in Patients With DM and CKD

DiaMedica Therapeutics Inc

Phase 1 Completed
33 enrolled
Lymphoid

Diabetes Mellitus, Lymphoma, Follicular, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡